Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk

European Journal of Radiology Open

Volumn 1, Issue 1, 2014, Pages 22-27

  de Souza, Nandita M ^a   Morgan, Veronica A ^a   Bancroft, Elizabeth ^a   Sohaib, S Aslam ^a   Giles, Sharon L ^a   Kote Jarai, Zsofia ^a   Castro, Elena ^a   Hazell, Steven ^a   Jafar, Maysam ^a   Eeles, Rosalind ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Detection; Diffusion weighted; Genetic risk; MRI; Prostate cancer; Screening

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; GENETIC ANALYSIS; GENETIC RISK; GENETIC SCREENING; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; POPULATION RISK; PRIORITY JOURNAL; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR BIOPSY;

EID: 84921961396     PISSN: None     EISSN: 23520477     Source Type: Journal    
DOI: 10.1016/j.ejro.2014.08.002     Document Type: Article

References (18)

1. Kote-Jarai Z, Leongamornlert D, Saunders E, Tymrakiewicz M, Castro E, Mahmud N, et al. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer 2011;105:123CM.
2. Madersbacher S, Alcaraz A, Emberton M, Hammerer P, Ponholzer A, Schroder FH, et al. The influence of family history on prostate cancer risk: implications for clinical management. BJU Int 2011;107:716-21.
3. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013 ;45:385-91.
4. Goh CL, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Thomas K, Selvadurai ED, et al. Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort. BJU Int 2013;l 12:666-73.
5. Thoeny HC, Forstner R, De Keyzer F. Genitourinary applications of diffusion-weighted MR imaging in the pelvis. Radiology 2012;263:326-42.
6. Park BK, Lee HM, Kim CK, Choi HY, Park JW. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Investig Radiol 2008;43:789-93.
7. Gibbs P, Liney GP, Pickles MD, Zelhof B, Rodrigues G, Turnbull LW. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Investig Radiol 2009;44:572-6.
8. Kitajima K, Takahashi S, Ueno Y, Miyake H, Fujisawa M, Kawakami F, et al. Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer. Eur J Radiol 2013;82:1219-26.
9. Nagarajan R, Margolis D, Raman S, Sarma MK, Sheng K, King CR, et al. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores. J Magn Resonan Imaging 2012;36:697-703.
10. Macinnis RJ, Antoniou AC, Eeles RA, Severi G, Al OlamaAA, McGuffog L, et al. A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. Genet Epidemiol 2011;35:549-56.
11. http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/risk/ statistics-on-the-risk-of-developing-cancer#Lifetime5.
12. Morgan VA, KyriaziS, Ashley SE, deSouzaNM. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol 2007;48:695-703.
13. deSouza NM, Reinsberg SA, Scurr ED, Brewster JM, Payne GS. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 2007;80: 90-5.
14. Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, et al. T2-weighted and diffusion-weighted MRI for localization of prostate cancer. Am J Roentgenol 2007; 189:323-8.
15. Kajihara H, Hayashida Y, Murakami R, Katahira K, Nishimura R, Hamada Y, et al. Usefulness of diffusion-weighted imaging in the localization of prostate cancer. Int J Radiat Oncol Biol Phys 2009;74:399-403.
16. Riches SF, Payne GS, Morgan VA, Sandhu S, Fisher C, Germuska M, et al. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. Am J Roentgenol 2009; 193:1583-91.
17. Srodon M, Epstein JI. Central zone histology of the prostate: a mimicker of high-grade prostatic intraepithelial neoplasia. Hum Pathol 2002;33:518-23.
18. Wilm BJ, Gamper U, Henning A, Pruessmann KP, Kollias SS, Boesiger P. Diffusion-weighted imaging of the entire spinal cord. NMR Biomed 2009;22:174-81.